American International Group’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-116,951
| Closed | -$1.73M | – | 1321 |
|
|
2024
Q1 | $1.73M | Buy |
116,951
+2,941
| +3% | +$43.6K | 0.01% | 1061 |
|
|
2023
Q4 | $927K | Sell |
114,010
-460
| -0.4% | -$3.74K | ﹤0.01% | 1330 |
|
|
2023
Q3 | $521K | Buy |
114,470
+14,334
| +14% | +$65.2K | ﹤0.01% | 1582 |
|
|
2023
Q2 | $705K | Buy |
100,136
+27,364
| +38% | +$193K | ﹤0.01% | 1444 |
|
|
2023
Q1 | $445K | Buy |
72,772
+1,449
| +2% | +$8.85K | ﹤0.01% | 1661 |
|
|
2022
Q4 | $456K | Sell |
71,323
-260
| -0.4% | -$1.66K | ﹤0.01% | 1643 |
|
|
2022
Q3 | $686K | Buy |
71,583
+1,011
| +1% | +$9.69K | 0.01% | 1385 |
|
|
2022
Q2 | $779K | Buy |
70,572
+68,627
| +3,528% | +$758K | 0.01% | 1345 |
|
|
2022
Q1 | $32K | Sell |
1,945
-29
| -1% | -$477 | ﹤0.01% | 2963 |
|
|
2021
Q4 | $38K | Sell |
1,974
-47
| -2% | -$905 | ﹤0.01% | 3019 |
|
|
2021
Q3 | $50K | Sell |
2,021
-175
| -8% | -$4.33K | ﹤0.01% | 3000 |
|
|
2021
Q2 | $57 | Sell |
2,196
-894
| -29% | -$23 | ﹤0.01% | 2984 |
|
|
2021
Q1 | $98 | Sell |
3,090
-369
| -11% | -$12 | ﹤0.01% | 2734 |
|
|
2020
Q4 | $160 | Sell |
3,459
-145
| -4% | -$7 | ﹤0.01% | 2395 |
|
|
2020
Q3 | $119K | Sell |
3,604
-96
| -3% | -$3.17K | ﹤0.01% | 2433 |
|
|
2020
Q2 | $102K | Sell |
3,700
-65,662
| -95% | -$1.81M | ﹤0.01% | 2525 |
|
|
2020
Q1 | $2.08M | Sell |
69,362
-4,006
| -5% | -$120K | 0.01% | 866 |
|
|
2019
Q4 | $2.03M | Buy |
73,368
+953
| +1% | +$26.4K | 0.01% | 989 |
|
|
2019
Q3 | $1.32M | Sell |
72,415
-504
| -0.7% | -$9.17K | 0.01% | 1152 |
|
|
2019
Q2 | $1.79M | Buy |
72,919
+5,404
| +8% | +$133K | 0.01% | 1050 |
|
|
2019
Q1 | $642K | Sell |
67,515
-2,188
| -3% | -$20.8K | ﹤0.01% | 1561 |
|
|
2018
Q4 | $617K | Buy |
69,703
+15,190
| +28% | +$134K | ﹤0.01% | 1551 |
|
|
2018
Q3 | $613K | Buy |
54,513
+982
| +2% | +$11K | ﹤0.01% | 1763 |
|
|
2018
Q2 | $685K | Buy |
53,531
+6,417
| +14% | +$82.1K | ﹤0.01% | 1628 |
|
|
2018
Q1 | $796K | Buy |
47,114
+5,644
| +14% | +$95.4K | ﹤0.01% | 1408 |
|
|
2017
Q4 | $332K | Buy |
41,470
+6,039
| +17% | +$48.3K | ﹤0.01% | 2022 |
|
|
2017
Q3 | $275K | Buy |
35,431
+2,649
| +8% | +$20.6K | ﹤0.01% | 2101 |
|
|
2017
Q2 | $241K | Sell |
32,782
-1,405
| -4% | -$10.3K | ﹤0.01% | 2164 |
|
|
2017
Q1 | $255K | Buy |
34,187
+8,007
| +31% | +$59.7K | ﹤0.01% | 2027 |
|
|
2016
Q4 | $182K | Sell |
26,180
-68
| -0.3% | -$473 | ﹤0.01% | 2239 |
|
|
2016
Q3 | $216K | Buy |
26,248
+40
| +0.2% | +$329 | ﹤0.01% | 2117 |
|
|
2016
Q2 | $212K | Sell |
26,208
-166
| -0.6% | -$1.35K | ﹤0.01% | 2091 |
|
|
2016
Q1 | $134K | Hold |
26,374
| – | – | ﹤0.01% | 3146 |
|
|
2015
Q4 | $204K | Sell |
26,374
-46
| -0.2% | -$356 | ﹤0.01% | 2817 |
|
|
2015
Q3 | $152K | Buy |
26,420
+31
| +0.1% | +$178 | ﹤0.01% | 3066 |
|
|
2015
Q2 | $242K | Buy |
+26,389
| New | +$242K | ﹤0.01% | 2842 |
|